TLR4 and Hepatic fibrosis: In contrast, DOP could inhibit the activation of the TLR4/NF-κB signaling pathway, thereby reducing the production of inflammatory factors such as TGF-β and TNF-α, and increasing the production of anti-inflammatory factors such as IL-10, therefore playing a significant role in preventing liver fibrosis.